Despite Aβ + being the hallmark characteristic of AD, younger Aβ- Met66 carriers do not show any change in CSF Aβ42, CSF tau, brain volume or cognition (Lim, et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.